← Eichor
Study identifier: NCT07604948 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Ischemic Preconditioning on Lower Extremity Motor Ability and Recovery in Basketball Players During Post-Match Recovery Period

Condition: Lower Extremity Explosive Power Deficit · Sports Recovery · Basketball Performance  ·  Sponsor: Guangzhou Sport University

PhaseNA
Planned participants34
Who can joinMale, 18 Years to 25 Years
Healthy volunteersYes

About this study

This study aimed to evaluate the effects of ischemic preconditioning on lower limb explosive power and post-exercise recovery in basketball players during a 6-week post-season recovery training period. Thirty-four male collegiate basketball players were randomly assigned to either an IPC group or a placebo control group. Bilateral lower limb IPC intervention (3 cycles, each consisting of 5-minute ischemia at 220 mmHg and 5-minute reperfusion, twice per week for 6 weeks) was administered before routine basketball training sessions. Lower limb explosive power, as well as physiological, biochemical, and morphological indices, were assessed before and after the intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Ziyue Ou, PHD  ·  +8615626121623  ·  105852022100090@stu.gzsport.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Guangzhou Sport UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07604948